OOIR: Observatory of International Research

Papers

(The H4-Index of Mini-Reviews in Medicinal Chemistry is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Meet the Section Editor	100
Synthetic Approaches and Pharmacological Attributes of Benzosuberone Skeleton	63
The Progress of Small Molecule Targeting BCR-ABL in the Treatment of Chronic Myeloid Leukemia	59
Withdrawal: Advances in Development of Drugs for Chronic Myelogenous Leukemia	56
Meet the Editorial Board Member	53
Sustainable Synthesis of Medicinally Important Heterocycles	52
The Application of the Pyrazole Structure in the Structural Modification of Natural Products	51
Cytotoxic Activity of Tropane Alkaloides of Species of Erythroxylum	48
Recent Progress and Perspectives in Sodium-Glucose Co-transporter 1/2 Inhibitors	46
Therapeutic Potental of Quinolin-2H-one Hybrids as Anticancer Agents	45
Meet Our Editorial Board Member	42
Acknowledgements to Reviewers	39
Meet Our Editorial Board Member	39
Meet the Section Editor	38
Chemical Synthesis of Selenium-containing Peptides	38
Meet the Editorial Board Member	37
Natural Products Databases for Drug Design	37
Radical Releasing Anti-tuberculosis Agents and the Treatment of Mycobacterial Tuberculosis Infections - An Overview	37
Protein and Small-Molecule Leucopoiesis and Thrombopoiesis Stimulators	37
Meet the Editorial Board Member	36
Roles of lncRNA-MALAT1 in the Progression and Prognosis of Gliomas	33
Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer	32
Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease	31
Meet the Editorial Board Member	31
A Systematic Review of Machine Learning Based Gait Characteristics in Parkinson’s Disease	30

Therapeutic Potential of Resveratrol in the Treatment of Glioma: Insights into its Regulatory Mechanisms	30
Chlorogenic Acid Derivatives: Structural Modifications, Drug Design, and Biological Activities: A Review	29
Meet the Editorial Board Member	28
Review on Characteristics and Analytical Methods of Remogliflozin Etabonate: An Update	28